American Regent
American Regent, Inc. has been supplying quality injectable products to the medical community throughout the US and Canada since 1967. Specialization in the nephrology market and expertise in manufacturing capabilities have enabled us to satisfy essential needs and establish a strong presence within the healthcare system. Our core values are customer service, quality, growth and partnership. We want you to not only consider us your IV injectable company, but also your partner and value-added resource for the services you require.
AmerisourceBergen
AmerisourceBergen is one of the world's largest pharmaceutical service companies serving the United States, Canada and selected global markets with a focus on the pharmaceutical supply channel. Servicing both pharmaceutical manufacturers and healthcare providers, the company provides drug distribution and related services designed to reduce costs and improve patient outcomes. Our scale, our position in the healthcare industry, and the value we bring to the channel have all helped our business continue to succeed.
Baxter
Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
Cardinal Health
Since 2001, Cardinal Health and the Cardinal Health Foundation have contributed more than $150 million in cash and product donations to non-profit organizations, domestically and abroad. We focus our philanthropic efforts on three program areas that are essential to healthcare, wellness, and community.
CareFusion
CareFusion is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The CareFusion family of products and services are used in over 120 countries and include some of the most widely recognized brand names in their categories.
The Johns Hopkins Hospital Department of Pharmacy
The Johns Hopkins Hospital is a world-renowned institution with a reputation for excellence in patient care, breakthrough discoveries in medical research and high-quality programs. It has been voted America's number-one hospital for the last 21 years in a row by U.S. News & World Report. The Department of Pharmacy, consistent with the mission of The Johns Hopkins Hospital, continuously strives for excellence in teaching, research, patient care and patient safety.
McKesson
McKesson Corporation, a FORTUNE 15 company, is a healthcare services and information technology company dedicated to helping its customers deliver high-quality healthcare by reducing costs, streamlining processes, and improving the quality and safety of patient care. McKesson has been in continuous operation for more than 176 years, making it the longest-operating company in healthcare today.
Mylan
Mylan Institutional combines the unique injectable portfolio of Bioniche
Pharma with the leading unit dose capabilities of UDL Laboratories. The
offering includes 52 injectable products and 455 SKUs in unit dose,
unit-of-use and automation-ready package formats.
Bioniche Pharma provides a broad range and reliable supply of high quality,
difficult-to-formulate or difficult-to-manufacture injectable products. UDL
brings product packaging innovations that help reduce dispensing errors,
increase efficiency and improve patient care. Together, Bioniche PHarma and
UDL-- as Mylan Institutional-- provide one powerful and customer-centric
offering to the institutional health care market.
Mylan Institutional is part of Mylan (Nasdaq: MYL), a Fortune 500 company
and one of the world's leading generic and specialty pharmaceuticals
companies, providing products to customers in more than 150 countries and
territories.
Omnicell
Omnicell, Inc., is a leading provider of systems targeting patient safety and operational efficiency in healthcare facilities. Since 1992, Omnicell has worked to enhance patient safety and allow clinicians to spend more time with their patients, through solutions for the central pharmacy, nursing unit, operating room, and patient bedside.
Pfizer Established Products Division
Good health is vital to all of us, and finding sustainable solutions to the most pressing health care challenges of our world cannot wait. That's why we at Pfizer are committed to applying science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe, effective and affordable medicines and related health care services to the people who need them.
RoundTable Healthcare Partners
RoundTable Healthcare Partners was founded in 2001 and is based in Lake Forest, Illinois. We have a unique combination of operating and transaction professionals who have worked together for more than 20 years, and have over 200 years of collective healthcare experience in medical products, devices, pharmaceuticals, and distribution.
RoundTable currently manages five investment funds, which total $1.9 billion of capital under management. Our first equity fund of $400 million was raised in 2001–2002. RoundTable made seven platform investments from Fund I in approximately three years. Our second equity fund of $500 million was raised in March 2005. RoundTable invested in six platform investments in Fund II over a period of approximately five and a half years. RoundTable raised its third, $600 million equity fund in July 2010. RoundTable Capital Partners, our $200 million subordinated debt fund, was raised in July 2006. RoundTable raised our second $200 million subordinated debt fund, RoundTable Capital Partners II, in July 2010.
Roxane
Roxane Laboratories, Inc., began operations as Columbus Pharmacal in 1885 as a regional pharmaceutical manufacturer based in downtown Columbus, Ohio. In 1959, Columbus Pharmacal was purchased by Philips of the Netherlands at which time the name was changed to Philips Roxane. Several years later in 1978, Philips Roxane was acquired by the German based pharmaceutical company Boehringer Ingelheim and the name was changed to Roxane Laboratories, Inc.
Roxane Laboratories operates as the research and development, sales and marketing arm of Boehringer Ingelheim’s multisource pharmaceutical business. Marketing more than 75 medications in more than 250 package sizes, Roxane Laboratories’ focus is on expanding our line of multisource pharmaceutical products including: bulk and unit-dose package configurations for liquids and solids; coated, sustained-release and controlled-release tablets; nasal sprays, topical solutions, cytotoxics, and CII narcotics.
Roxane Laboratories’ affiliate, Boehringer Ingelheim Roxane, Inc. (BIRI), functions as the primary production site for the multisource non-sterile pharmaceuticals. Located on the same Columbus campus as Roxane Laboratories, BIRI operates out of a modern 500,000 square foot manufacturing and laboratory facility that spans 70 acres and employs approximately 1,000 people. This campus also functions as a primary launch site for new Boehringer Ingelheim product launches.
Sagent Pharmaceuticals
Most companies are built from the ground up. We decided to build SAGENT from the customer out. By focusing on customers’ needs, we’ve built in the attributes you told us matter to you most. Excellence is our standard, our motivation and our guide. We believe the measure of success is determined by you, our customers, and how well we are addressing your needs every day. SAGENT is a customer-focused company, delivering an extensive portfolio of injectable products and fulfilling the evolving needs of the patients we serve through our unique network of global resources.
Samson Medical Technologies, L.L.C.
Samson Medical Technologies, L.L.C., is a privately-held company focused on providing hospital and alternate site pharmacists with injectable drug delivery systems and programs designed to meet their unique needs. Samson Medical Technologies is small enough to listen to customers and large enough to supply what pharmacists want.
TEVA
With 45,000 employees in 60 countries, Teva is dynamic and diverse and, at the same time, adheres to a common set of values and vision. We plan to continue leading the pharmaceutical industry by remaining diligently committed to our patients.